Effective Strategies to Predict Survival of Colorectal Peritoneal Metastases Patients Eligible for Cytoreductive Surgery and HIPEC

Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC), often combined with systemic therapy, can be offered to selected colorectal peritoneal metastases (PM) patients. However, clinical heterogeneity and the lack of high-level evidence challenges determination of the corr...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer Manag Res
Autors principals: Simkens, Geert A, Wintjens, Anne G W E, Rovers, Koen P, Nienhuijs, Simon W, de Hingh, Ignace H
Format: Artigo
Idioma:Inglês
Publicat: Dove 2021
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8257566/
https://ncbi.nlm.nih.gov/pubmed/34234566
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S277912
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars